Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Aldo Morrone and Gennaro Ciliberto.
Aldo Morrone
Connection Strength
0.767
Gennaro Ciliberto
  1. Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI. Vaccines (Basel). 2021 Jun 22; 9(7).
    View in: PubMed
    Score: 0.238
  2. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine. 2021 Jun; 36:100928.
    View in: PubMed
    Score: 0.237
  3. COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial. Front Immunol. 2021; 12:704110.
    View in: PubMed
    Score: 0.060
  4. Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia. J Hematol Oncol. 2021 07 29; 14(1):119.
    View in: PubMed
    Score: 0.060
  5. Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution. J Hematol Oncol. 2021 05 17; 14(1):81.
    View in: PubMed
    Score: 0.059
  6. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients. J Exp Clin Cancer Res. 2020 Sep 23; 39(1):200.
    View in: PubMed
    Score: 0.057
  7. Reorganization of Istituti Fisioterapici Ospitalieri, an oncological and dermatological clinical and research center, to face the coronavirus health emergency: adopted measures and metrics of success to achieve and keep a COVID-19-free status. J Exp Clin Cancer Res. 2020 Sep 01; 39(1):177.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.